October 01, 2016 9:42 AM ET

Professional Services

Company Overview of H. Lee Moffitt Cancer Center & Research Institute

Company Overview

H. Lee Moffitt Cancer Center & Research Institute is a not for-profit institution that focuses on prevention and cure of cancer. The institution offers private patient rooms, blood and marrow transplant programs, outpatient treatment programs, patient care, research, and education services. Additionally, it publishes Today's Tomorrows, a community newsletter about cancer care, research, and education. H. Lee Moffitt was founded in 1986 and is based in Tampa, Florida.

10441 University Center Drive

Tampa, FL 33612

United States

Founded in 1986



Key Executives for H. Lee Moffitt Cancer Center & Research Institute

Chief Executive Officer and Center Director
Age: 66
Executive Vice President Applied Science
Vice President of Public Relations and Marketing
Compensation as of Fiscal Year 2016.

H. Lee Moffitt Cancer Center & Research Institute Key Developments

H. Lee Moffitt Cancer Center & Research Institute Presents at Sachs Associates 2nd Annual Immune-Oncology BD&L and Investment Forum, Jun-03-2016

H. Lee Moffitt Cancer Center & Research Institute Presents at Sachs Associates 2nd Annual Immune-Oncology BD&L and Investment Forum, Jun-03-2016. Venue: Hyatt Chicago Magnificent Mile, 633 North Saint Clair Street, Chicago, IL 60611, United States. Presentation Date & Speakers: Jun-03-2016, James J. Mule, Executive Vice President Applied Science, Paul Rennert, Founder & Principal.

Moffitt Cancer Center Names Kevin Pickett as Executive Vice President and Chief Philanthropy Officer

Moffitt Cancer Center in Tampa has named its first-ever, high-ranking executive to provide a strategic philanthropy vision for its foundation. Kevin Pickett was named executive vice president and chief philanthropy officer. In this role, he will oversee the vice president of the Moffitt Cancer Center Foundation and its team, working to identify philanthropic priorities. Pickett previously served as executive director of development for the University of Texas MD Anderson Cancer Center in Houston.

Moffitt Cancer Center and Ignyta, Inc. Enter into Cancer Research Collaboration for RXDX-106

Moffitt Cancer Center and Ignyta, Inc. announced that they have entered into research collaboration relating to RXDX-106, Ignyta's small molecule, pseudo irreversible inhibitor of TYRO3, AXL, Mer (TAM) and cMET that is in late stage preclinical development. The collaboration, which will be conducted in the labs of Eric B. Haura, M.D., director of the Lung Cancer Center of Excellence and leader of the Chemical Biology and Molecular Medicine Program at Moffitt, will explore and develop novel protein based diagnostic assays that can assess RXDX-106 signaling activity in relevant solid tumors and associated tumor microenvironments.

Similar Private Companies By Industry

Company Name Region
1-2-3 Payroll & HR Services, Inc. United States
123College.com, Inc. United States
13D Research LLC United States
151 Ventures, LLC United States
1790 Analytics, LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Bloomberg L.P. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact H. Lee Moffitt Cancer Center & Research Institute, please visit www.moffitt.usf.edu. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.